| SC 13G/A | 2019-02-12 | Flynn James E | Kiniksa Pharmaceuticals, Ltd. | 1,128,822 | 7.2% | EDGAR |
| SC 13G | 2019-02-11 | VANGUARD GROUP INC | Kiniksa Pharmaceuticals, Ltd. | 908,273 | 5.8% | EDGAR |
| SC 13D/A | 2019-02-06 | BAKER BROS. ADVISORS LP | Kiniksa Pharmaceuticals, Ltd. | 3,031,268 | 16.1% | EDGAR |
| SC 13G | 2018-07-19 | Desnick Robert | Kiniksa Pharmaceuticals, Ltd. | 932,851 | 5.8% | EDGAR |
| SC 13G | 2018-06-04 | Cormorant Asset Management, LP | Kiniksa Pharmaceuticals, Ltd. | 161,962 | - | EDGAR |
| SC 13D | 2018-05-31 | BAKER BROS. ADVISORS LP | Kiniksa Pharmaceuticals, Ltd. | 3,006,252 | 20.4% | EDGAR |
| SC 13G | 2018-05-31 | Flynn James E | Kiniksa Pharmaceuticals, Ltd. | 1,226,890 | 8.3% | EDGAR |